In 2020, cancer diagnoses will thrust nearly 2 million Americans into the often bewildering world of treatments and clinical trials. TrialJectory aims to help. The service uses AI to read through thousands of clinical trials and extract information about the sorts of patients the researchers are looking for. Its algorithm then matches users with the clinical trials—like the one a patient found for her Stage IV metastatic breast cancer—based on the users’ responses to a series of questions about themselves and their disease progression. Since launching in 2018, TrialJectory’s researchers have expanded the system to cover more types of cancer, adding lung cancers this summer. —Alejandro de la Garza
More Must-Reads From TIME
- Global Climate Solutions Exist. It's Time to Deploy Them
- What Happens to Diane Feinstein's Senate Seat
- Who The Golden Bachelor Leaves Out
- Rooftop Solar Power Has a Dark Side
- How Sara Reardon Became the 'Vagina Whisperer'
- Is It Flu, COVID-19, or RSV? Navigating At-Home Tests
- Kerry Washington: The Story of My Abortion
- Want Weekly Recs on What to Watch, Read, and More? Sign Up for Worth Your Time
